MXPA04005179A - Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y una antibiotico de (-lactama. - Google Patents

Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y una antibiotico de (-lactama.

Info

Publication number
MXPA04005179A
MXPA04005179A MXPA04005179A MXPA04005179A MXPA04005179A MX PA04005179 A MXPA04005179 A MX PA04005179A MX PA04005179 A MXPA04005179 A MX PA04005179A MX PA04005179 A MXPA04005179 A MX PA04005179A MX PA04005179 A MXPA04005179 A MX PA04005179A
Authority
MX
Mexico
Prior art keywords
gemifloxacin
beta
salt
bacterial infections
lactam antibiotic
Prior art date
Application number
MXPA04005179A
Other languages
English (en)
Inventor
Youn Ha-Sik
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Publication of MXPA04005179A publication Critical patent/MXPA04005179A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invencion se relaciona a un metodo para tratar infecciones antibacterianas, el metodo que comprende la administracion separada, simultanea o secuencial a un paciente en necesidad del mismo, de una cantidad efectiva de gemifloxaxina o una sal de la misma y un antibiotico de ??-lactama.
MXPA04005179A 2001-11-30 2002-11-29 Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y una antibiotico de (-lactama. MXPA04005179A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33449501P 2001-11-30 2001-11-30
PCT/KR2002/002248 WO2003045390A1 (en) 2001-11-30 2002-11-29 A METHOD OF TREATING BACTERIAL INFECTIONS USING GEMIFLOXACIN OR A SALT THEREOF AND A β -LACTAM ANTIBIOTIC

Publications (1)

Publication Number Publication Date
MXPA04005179A true MXPA04005179A (es) 2004-08-11

Family

ID=23307473

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005179A MXPA04005179A (es) 2001-11-30 2002-11-29 Un metodo para tratar infecciones bacterianas usando gemifloxacina o una sal de la misma y una antibiotico de (-lactama.

Country Status (13)

Country Link
US (1) US7169792B2 (es)
EP (1) EP1458391B1 (es)
AT (1) ATE372119T1 (es)
AU (1) AU2002360218A1 (es)
CA (1) CA2468036C (es)
CY (1) CY1107038T1 (es)
DE (1) DE60222298T2 (es)
DK (1) DK1458391T3 (es)
ES (1) ES2292844T3 (es)
MX (1) MXPA04005179A (es)
NO (1) NO333196B1 (es)
PT (1) PT1458391E (es)
WO (1) WO2003045390A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011101710A1 (en) * 2010-02-16 2011-08-25 Wockhardt Research Centre Efflux pump inhibitors
ITMI20080289A1 (it) * 2008-02-22 2009-08-23 S I F I Societa Industria Farmaceutica Italia Composizioni di gemifloxacina con elevata efficacia su patologie oculari
EP2143422A1 (en) * 2008-07-11 2010-01-13 S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A. Ophthalmic compositions containing gemifloxacin for the treatment of ocular infections
EA201290827A1 (ru) * 2010-02-25 2013-03-29 Сантен Фармасьютикал Ко., Лтд. Офтальмологический раствор для лечения глазной инфекции, содержащий левофлоксацин или его соль или сольват этих соединений, способ лечения глазной инфекции, левофлоксацин или его соль или сольват этих соединений и их применение

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3711343A1 (de) * 1987-04-03 1988-10-20 Bayer Ag Cephalosporinderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis

Also Published As

Publication number Publication date
EP1458391B1 (en) 2007-09-05
DE60222298T2 (de) 2008-01-03
ES2292844T3 (es) 2008-03-16
ATE372119T1 (de) 2007-09-15
DK1458391T3 (da) 2008-01-07
EP1458391A4 (en) 2005-05-11
CA2468036A1 (en) 2003-06-05
NO333196B1 (no) 2013-04-02
DE60222298D1 (de) 2007-10-18
NO20042711L (no) 2004-06-30
US7169792B2 (en) 2007-01-30
PT1458391E (pt) 2007-12-10
CA2468036C (en) 2008-01-22
EP1458391A1 (en) 2004-09-22
CY1107038T1 (el) 2012-09-26
WO2003045390A1 (en) 2003-06-05
US20050148571A1 (en) 2005-07-07
AU2002360218A1 (en) 2003-06-10

Similar Documents

Publication Publication Date Title
AU6339599A (en) Quinoline derivatives and their use as antibacterial agents
MXPA03003168A (es) Composicion antibiotica topica para el tratamiento de infeccion de los ojos.
AU2002328972A1 (en) Piperidine derivatives as antibacterial agents
MY138285A (en) Fab i inhibitors
PT759774E (pt) Metodo para o tratamento de infeccoes bacterianas gram-negativas por administracao de um produto de proteina bactericida indutora da permeabilidade (bip) e de um antibiotico
WO2001092288A3 (en) Cobalamin compounds useful as antibiotic agents and as imaging agents
AU2003291227A8 (en) Antibacterial agents
TW200507841A (en) Antibacterial agents
MXPA02001254A (es) Formulacion de moxifloxacino con sal-comun.
AU2003303956A8 (en) Antibacterial agents
WO2005046579A3 (en) Defined dose therapeutic phage
PT1565201T (pt) Métodos de administração de dalbavancina para o tratamento de infeções bacterianas
EP1057828A3 (en) Trovafloxacin oral suspensions
IL162689A0 (en) Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
AU7594301A (en) Derivatives of laspartomycin and preparation and use thereof
WO2004098500A3 (en) CARBACEPHEM ss-LACTAM ANTIBIOTICS
WO2003061704A3 (en) Combination therapy for the treatment of bacterial infections
PT1458390E (pt) Um método para tratar infecções bacterianas utilizando gemifloxacina ou um seu sal e um agente antibacteriano carbapenem
AUPR916101A0 (en) Method of treating halitosis
AU2003209241A1 (en) Antimicrobial thiadiazinone derivatives useful in treatment of bacterial infections
AU2003267962A8 (en) Antibacterial compounds and methods for treating gram positive bacterial infections
PL370662A1 (en) Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
WO2003053959A8 (de) Heterocyclylaminocarbo nyluracile

Legal Events

Date Code Title Description
FG Grant or registration